VIYASH259.00

Viyash Scientific Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAARTIDRUGSYATHARTHTHYROCARESUPRIYASTARSPARCSHILPAMEDRUBICONMcap ₹11,314 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,369.71,551.43,420.33,148.7
Other Income11.014.743.640.4
Total Income1,380.71,566.13,463.93,189.1
Expenses
+ Cost of Materials Consumed613.7617.41,376.91,296.3
+ Purchases of Stock-in-Trade175.5212.6250.6259.1
+ Changes in Inventories-29.5-18.1-64.8-104.3
+ Employee Benefit Expense250.6281.1565.5531.9
+ Finance Costs48.160.869.257.3
+ Depreciation & Amortisation61.566.5233.6196.2
+ Other Expenses298.0296.6639.6571.8
Total Expenses1,417.91,516.83,070.62,808.2
EBITDA61.4161.8652.5593.9
EBIT-0.195.3418.9397.8
Profit
PBT before Exceptional Items-37.349.3393.2380.8
+ Exceptional Items-17.4-5.0-44.2-43.0
Pretax Income-54.644.3349.0337.9
+ Current Tax13.940.963.243.1
+ Deferred Tax-39.0-28.861.281.0
Tax Expense-25.012.1124.4124.1
Net Income-29.632.3224.7213.8
+ Net Income — Continuing Ops-29.632.3224.7213.8
+ Other Comprehensive Income-65.2-21.6106.949.9
Total Comprehensive Income-94.810.7331.6263.7
Net Income to Common-35.921.9177.3171.2
Minority Interest6.310.447.442.6
Per Share
Basic EPS-1.440.884.094.19
Diluted EPS-1.440.854.014.09
Other Comprehensive Income — detail
+ Other Comprehensive Income-21.6106.949.9
+ Items NOT to be Reclassified to P&L-1.3-0.7-3.1-3.5
+ Tax on Items NOT to be Reclassified-0.2-0.8-0.9
+ Tax on Items NOT to be Reclassified — alt tag0.1
+ Items to be Reclassified to P&L-63.8-21.2109.252.6
Comprehensive Income — Owners of Parent-65.4-0.1256.3205.3
Comprehensive Income — Non-controlling Interests0.310.775.258.5
Per Share — as-filed variants
Basic EPS — Continuing Operations-1.440.884.094.19
Diluted EPS — Continuing Operations-1.440.854.014.09
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit610.0739.51,857.61,697.6
Gross Margin %44.5347.6754.3153.91
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-37.349.3393.2380.8
− Exceptional Items (reconciliation)-17.4-5.0-44.2-43.0
Net Income Adj (tax-effected)-20.235.9253.1241.0
EPS Adj-0.980.984.614.72
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital49.950.187.487.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.